Newsroom

Featured

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

January 10, 2025

PR Newswire

$3M grant to accelerate development of neuroplastogens for substance use disorder treatment

October 28, 2024

PR Newswire

$6 million boost for industry research projects

October 25, 2024

The University of Sydney

Highlights

Psylo Partnership to Deliver Psychedelic Treatments for Mental Health

June 27, 2024

University of Sydney

Psylo's US trip: why the psychedelics startup is keeping one foot in Autralia as it expands stateside

June 24, 2024

Capital Brief

Should Next-Generation Psychdelics Skip the Trip?

April 22, 2024

Scientific American

Next-generation psychedelics: should new agents skip the trip?

April 3, 2024

Nature Biotechnology

Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens at BIO Conference in San Diego

April 3, 2024

PR Newswire

Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic Compounds

March 1, 2024

Psychedelics Today

Next-Generation Psychedelics, WIthout the Hallucinations?

November 3, 2023

TEDxSydney

Phil Morle on everything VC Main Sequence Ventures is doing at SXSW (and some other events that caught his eye)

October 12, 2023

Startup Daily

Dr Will Jorgensen was a guest on the 018 Hello Tomorrow AP 2023 Recap Show

September 27, 2023

One North Stories

Dr. Dilara Bahceci: Future Medicine

August 8, 2023

Humans of Purpose

Lifting Depression: Are hallucinations compulsory?

August 7, 2023

Cosmos

Dr. Sam Banister - Psychdelics 2.0 and beyond

July 1, 2023

Entheogenesis Australis

PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES

June 22, 2023

PR Newswire

Australia's food, drug and finance regulators can be progressive

June 20, 2023

Australia's FInancial Review

MDMA and Psilocybin are now legal in Australia. Here’s what you need to know

June 19, 2023

Forbes

Dr. Alex Kwan featured: Timing is key for behavioral benefits of psychedelics

June 14, 2023

Nature

Dr. Mario de la Fuente featured: WTF is head twitch?

June 13, 2023

Your Brain on Science

A reawakening of Psychedelics Research - Discovery, Design and Development of New Treatments

March 28, 2023

CDD Vault

Biotechs scramble as Australia leads world in psychedelics

February 6, 2023

Australia's FInancial Review

Treating mental illness: the Power of Psychedelics

December 28, 2022

TechBio Founders

UNSW Founders 2022 10x Accelerator Demo Day showcases next herd of unicorns to investors

November 22, 2022

UNSW Founders

Dr. Will Jorgensen featured on The Lead Candidate

October 17, 2022

The Lead Coandidate

UNSW Science Partner Stories

September 1, 2022

UNSW Community

Psychoactive drugs with Hamilton Morris

April 1, 2022

All Coverage

How Psylo and Enosis Therapeutics are using tech to tackle medicinal psychdelics

September 18, 2024

Smart Company

Pα+ Psychedelic Bulletin #166

July 5, 2024

Psychedelic Alpha Bulletin

Five Aussie startups that raised $54.4 million this week

April 7, 2024

Smart Company

Biotech startup Psylo closes $8m seed round on psychedelic treatment

April 4, 2024

Capital Brief

Superseeder: psychedelic biotech Psylo plants $12 million in latest ‘Seed’ round

April 4, 2024

Startup Daily

Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development and a Vision for More Equitable Drug Development

January 25, 2024

Psychedelic Alpha

MDMA & Ketamine: the New Frontiers of Mental Health with Dilara Bahceci

November 4, 2023

OnTracka

Dr. Dilara Bahceci featured: How are psychedelic drugs being used to treat mental illness and why is Australia a world leader in this space?

August 30, 2023

The Scan

Pα+ Psychedelic Bulletin #140

June 29, 2023

Psychedelic Alpha

Bend your mind around this: the great medicinal psychedelic rival has begun

June 7, 2023

Crikey

Mind the Gap

May 15, 2023

Mind the Gap

Magic Mushrooms: The therapeutics of the future?

April 1, 2023

Raising the Bar

Psylo reaction to TGA down-scheduling psilocybin and MDMA

February 2, 2023

Medium

Synthetic biology could change the way we grow food and manufacture essentials

January 9, 2023

Channel 9 News Australia

The 'renaissance' of psychedelic therapy in mental health

January 6, 2023

Australia's FInancial Review

Psychedelics With Purpose

November 2, 2022

Matters

The big name VCs backing Aussie magic mushrooms start-up

October 27, 2022

Australia's FInancial Review

Psychedelic Alpha Interview with Josh Ismin

August 19, 2022

Psychdelic Alpha

What the science says about microdosing

April 8, 2022

Australian Financial Review

Pα+ Psychedelic Bulletin #179

Psychedelic Alpha Bulletin